1. Pink Sheet

Opioid Abuse: The Limits Of Industry’s Response

 
• By Michael McCaughan

PhRMA is endorsing dispensing limits on opioids and pledging to support a public/private partnership to develop new treatments and alternatives. But members of a Presidential Commission didn’t seem impressed.

Hitting bigger business target
PhRMA feels its pledge is hitting a big target; policymakers may have bigger ideas.

The brand-name pharmaceutical industry is supporting efforts to put limits on initial opioid prescriptions – but the immediate response to the gesture was limited praise.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance